(TSX-V:EMO),(OTC US:EMOTF),(Other OTC:EMOTF),(Frankfurt:LLJA), TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) announces a 1,536km Helicopter time-domain electromagnetic and magnetic (HTEM) aerial geophysical survey over the Iberian Belt West (IBW) project and the adjacent San Antonio exploration project to commence in December 2025. The […]

(NYSE MKT:ATCH), TAMPA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking, today announced that its wholly owned subsidiary, Wilson-Davis & Co. (“WDCO”), has filed its October 2025 FOCUS Report with FINRA, reflecting another month of

(NASDAQ:KALA), ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the purchase

(NasdaqGM:BCAX), Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW dose Data inform and advance progress toward dose selection for ongoing pivotal FORTIFI-HN01 clinical trial of ficerafusp alfa in combination with pembrolizumab in 1L HPV-negative R/M HNSCC Company to host conference call and webcast

(TSX-V:IVS), TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to report the results from its 007 North bulk sample at its wholly-owned Pardo Gold Project, located 65 km northeast of Sudbury, Ontario. Highlights A total of 427 ounces of gold recovered from 4,674 dry tonnes

(Euronext Amsterdam:TOM2), AMSTERDAM, Dec. 01, 2025 (GLOBE NEWSWIRE) — TomTom (TOM2), the location technology specialist, today released a new report examining how road congestion around major U.S. airports shifts during the country's busiest travel periods, including the recent federal shutdown that stretched across November and contributed to widespread flight cancellations. Drawing on multi-year data across

(NASDAQ:SEER), REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the publication in Nature Genetics of a large genome-wide association study (GWAS) that used the company's Proteograph(R) Product Suite to measure proteins at peptide-level resolution and map their genetic

(NASDAQ:CGEM), Promising efficacy and favorable safety data from the Phase 1 study in heavily pre-treated patients show potential of CLN-049 to address a broad population of AML patients CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases

(NasdaqGM:GUTS), BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating

(NASDAQ:SNDX), NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET. A live webcast